Phadia ImmunoCAP Tryptase Fluoroenzymeimmunoassay - HSA Registration DE0019150
Access comprehensive regulatory information for Phadia ImmunoCAP Tryptase Fluoroenzymeimmunoassay in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0019150 and owned by Phadia AB. The device was registered on April 10, 2017.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
ImmunoCAP Tryptase is an immunoassay for the quantitative measurement of tryptase in human serum or plasma. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of systemic mastocytosis and mast cell activation events, in conjunction with other clinical findings. ImmunoCAP Tryptase is to be used in clinical laboratories and with the instruments Phadia 100, Phadia 250 or Phadia 1000.

